Shilpa Medicare Ltd 2015 AR2
The report outlines the financial and operational performance of Shilpa Medicare Limited for the fiscal year 2014-2015. During the year, the company focused on expanding its oncology and API manufacturing facilities, receiving approvals from regulatory bodies such as USFDA, Cofepri, Anvisa, and EU. The company invested Rs. 2,793.28 lakhs in research and development, leading to successful product transfers and patent filings. Additionally, the company continued its commitment to environmental sustainability and corporate social responsibility, focusing on safe drinking water, education, and rural development initiatives.
Company: Shilpa Medicare Ltd
Sector: Manufacturing
Country: India
Year: 2015
Type: AR2
Pages: 112
Back to company
Shilpa Medicare Ltd
Annual Report
The report outlines the financial and operational performance of Shilpa Medicare Limited for the fiscal year 2014-2015. During the year, the company focused on expanding its oncology and API manufacturing facilities, receiving approvals from regulatory bodies such as USFDA, Cofepri, Anvisa, and EU. The company invested Rs. 2,793.28 lakhs in research and development, leading to successful product transfers and patent filings. Additionally, the company continued its commitment to environmental sustainability and corporate social responsibility, focusing on safe drinking water, education, and rural development initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Apr 1, 2014 - Mar 31, 2015
Fiscal Year
2015
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees